TARA
Conviction 9HealthcareScan · Fri, Oct 2, 2026Protara Therapeutics, Inc. (TARA) closed at $2.70 (-2.17%) on Oct 2, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 19, RS Rating 16, -64.3% from its 52-week high, -49.8% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in TARA
Insider activity
SEC Form 4 transactions in TARA
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BESHAR LUKE M Director · Stock Option (Right to Buy) · 2026-06-15 | Grant | 31K | — | 2026-06-15 | 2026-06-16 |
SEC filings
EDGAR filings in TARA · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.